497833-27-9
497833-27-9
Chemical Structure
Givinostat
Synonym(s): ITF-2357
- CAS No.: 497833-27-9
- Formula:C24H27N3O4
- Molecular Weight:421.49
IUPAC Name: (6-((diethylamino)methyl)naphthalen-2-yl)methyl (4-(hydroxycarbamoyl)phenyl)carbamate
InChIKey: YALNUENQHAQXEA-UHFFFAOYSA-N
SMILES: O=C(OCC1=CC=C2C=C(CN(CC)CC)C=CC2=C1)NC3=CC=C(C(NO)=O)C=C3
Biological Activity: Givinostat (ITF-2357) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. Givinostat can be used for Duchenne muscular dystrophy (DMD) research. Givinostat can penetrate the blood-brain barrier (BBB)[1][2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Givinostat | 98.67% | Givinostat (ITF-2357) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. Givinostat can be used for Duchenne muscular dystrophy (DMD) research. Givinostat can penetrate the blood-brain barrier (BBB). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Givinostat (Standard) | ≥98% | Givinostat (Standard) is the analytical standard of Givinostat. This product is intended for research and analytical applications. Givinostat (ITF-2357) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. Givinostat can be used for Duchenne muscular dystrophy (DMD) research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.99
HY-14842ARGivinostat hydrochloride (Standard) -
Similarity Score 0.98
HY-14842BGivinostat hydrochloride monohydrate -
Similarity Score 0.59
HY-147731HDAC6-IN-9 -
Similarity Score 0.57
HY-162060YPX-C-05 -
Similarity Score 0.55
HY-149418BChE/HDAC6-IN-2 -
Similarity Score 0.55
HY-157314HDAC6-IN-27 -
Similarity Score 0.55
HY-16699Nexturastat A -
Similarity Score 0.54
HY-12163Entinostat -
Similarity Score 0.54
![4,4′,4′′-[Nitrilotris(methylene)]tris[benzoic acid] Chemical Structure](//file.medchemexpress.com/product_pic/hy-w586967.gif)
HY-W5869674,4′,4′′-[Nitrilotris(methylene)]tris[benzoic acid] -
Explore the MedChemAI to find more analogs
![4,4′,4′′-[Nitrilotris(methylene)]tris[benzoic acid] Chemical Structure](http://file.medchemexpress.com/product_pic/hy-w586967.gif)
References
- [1]. Li S, et al. Specific inhibition of histone deacetylase 8 reduces gene expression and production of proinflammatory cytokines in vitro and in vivo. J Biol Chem. 2015 Jan 23;290(4):2368-78. [Content Brief]
- [2]. Leoni F, et al. The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo. Mol Med. 2005 Jan-Dec;11(1-12):1-15. [Content Brief]
- [3]. Wang YG, et al. Givinostat inhibition of hepatic stellate cell proliferation and protein acetylation. World J Gastroenterol. 2015 Jul 21;21(27):8326-39. [Content Brief]
- [4]. Taiarol L, et al. Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics. Cancers (Basel). 2022 Jun 16;14(12):2978. [Content Brief]
